Guggenheim analyst Rohit Vanjani has initiated coverage of the dermatology space, announcing ratings on four pharmaceuticals stocks. We don’t have time to cover …
What does the future hold for Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)? Raymond James analyst Elliot Wilbur is out today with a bullish note on …
Jim Simons, the founder of one of the world’s most successful hedge funds, is splashing out on controversial healthcare stock Valeant Pharmaceuticals (NYSE:VRX). …
Bluebird Bio Inc (NASDAQ:BLUE) just attracted another bull to its biotech table, with Canaccord analyst John Newman believing the company’s collaboration with Celgene …
Himax Technologies (NASDAQ:HIMX) is a semiconductor company that may have met its match: lackluster 3D sensing revenue just around the corner. Rosenblatt analyst …
Analyst James Jang and his team cut their rating on Pyxis Tankers Inc (NASDAQ:PXS) from Buy to Hold, with a $3.00 price target.
Valeant Pharmaceuticals (NYSE:VRX) management boiled down its position to BTIG analyst Tim Chiang, where the discussion gravitated on the standing of the company’s …
Nutanix Inc. (NASDAQ:NTNX) keeps producing earnings results that blow away Wall Street estimates, says Oppenheimer analyst Ittai Kidron in raising his price target on …
Adamis Pharmaceuticals (NASDAQ:ADMP) investors sent the stock on a nearly 9% gain in value yesterday on back of the news of the company’s …
Alibaba Group (NYSE:BABA) is on a roll after a record-profitable Singles Day, China’s gift of an anti-Valentine’s Day for singles in terms of …
